Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 67 publications
Incidence and clinical features of cataracts: an under-recognized adverse event with mirvetuximab soravtansine-gynx in ovarian cancer.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: February 18, 2026
Patient outcomes in advanced ovarian cancer treated with an anti-FOLR1 antibody-drug conjugate.
Journal: Gynecologic oncology
Published: January 27, 2025
Epigenetic Therapy in a Rare Ovarian Cancer - A Double-Edged Sword.
Journal: The New England journal of medicine
Published: August 21, 2024
Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 05, 2024
A Phase II Study of Fulvestrant plus Abemaciclib in Hormone Receptor-Positive Advanced or Recurrent Endometrial Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 25, 2024
Vaccination with folate receptor-alpha peptides in patients with ovarian cancer following response to platinum-based therapy: A randomized, multicenter clinical trial.
Journal: Gynecologic oncology
Published: June 11, 2024
Mirvetuximab soravtansine in folate receptor alpha (FRα)-high platinum-resistant ovarian cancer: final overall survival and post hoc sequence of therapy subgroup results from the SORAYA trial.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: June 10, 2024
Reply to Z.R. McCaw et al.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 03, 2023
Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets.
Assessing the Genomic Landscape of Cervical Cancers: Clinical Opportunities and Therapeutic Targets.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 12, 2023
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 30, 2023
Last Updated: 09/26/2026